Protective Effect of Tetramethylpyrazine on Myocardial Ischemia-Reperfusion Injury

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Pharmacological action</td><td align="center">Methods</td><td align="center">Reference</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left" rowspan="3">Interference with the inflammatory reaction</td><td align="center">Decrease activity of p38MAPK </td><td align="center">
                  Castaneda et al. 2003 [<a href="/journals/ecam/2014/107501/#B58">58</a>]</td></tr><tr><td align="center">Inhibit the expression of E-selectin and P-selectin</td><td align="center">
                  Shang et al. 2008 [<a href="/journals/ecam/2014/107501/#B59">59</a>]</td></tr><tr><td align="center">Inhibit ICAM-1 expression </td><td align="center">
                  Pan and Jin 2008 [<a href="/journals/ecam/2014/107501/#B60">60</a>]</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Interference with the inflammatory reaction.

Evidence-Based Complementary and Alternative Medicine

tab5

Table 5

Table 5: Protective Effect of Tetramethylpyrazine on Myocardial Ischemia-Reperfusion Injury 